Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Belluscura
Plano, Texas, United Statesbelluscura.com ↗
- Ownership
- Private
- Employees
- ~35
- Development stage
- Commercial
01
Overview
Belluscura has commercialized lightweight portable oxygen concentrators such as X‑PLOR® and DISCOV-R™, both cleared for use in the US. These devices deliver up to ~95% pure oxygen continuously. The company holds or licenses over two dozen patents related to its core technologies. Future development includes next-generation stationary concentrators, wound care, drug delivery systems, and a portable artificial lung. Clinical results are not applicable as these are medical devices rather than drugs.
- Therapeutic areas
- PulmonologyInfectious Diseases
- Modalities
- Device (Portable oxygen concentrator)Drug delivery deviceWound care deviceArtificial lung
- Industry
- Therapeutic Medical Devices
02
Partnerships
Stryker licensing agreement for certain medical devices/STIC product line acquisition from Strykerco-development with Separation Design Group
Beyond the preview
Go deeper on Belluscura.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Belluscura.